Large-scale testing (Phase 3)Study completedNCT00003638What this trial is testingVaccine Therapy in Treating Women With Metastatic Breast CancerWho this might be right forBreast Cancer Oncothyreon Canada Inc. 950
Testing effectiveness (Phase 2)Active Not RecruitingNCT04550494What this trial is testingMeasuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair VariationsWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Castration-Resistant Prostate Carcinoma+28 more National Cancer Institute (NCI) 29
Not applicableStudy completedNCT06500858What this trial is testingMBC Physical Activity StudyWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Metastatic Breast Carcinoma Thomas Jefferson University 12
Early research (Phase 1)WithdrawnNCT06590558What this trial is testingTesting the Addition of an Investigational Anti-Cancer Drug, ASTX660 (Tolinapant), to a Usual Chemotherapy Treatment (Eribulin) for Treatment of Advanced Triple Negative Breast CancerWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Invasive Breast Carcinoma+9 more National Cancer Institute (NCI)
Not applicableLooking for participantsNCT07258563What this trial is testingThe TASTY-steering StudyWho this might be right forMetastatic Triple Negative Breast CancerMetastatic Testicular CancerStage II-IV Diffuse Large B Cell Lymphoma University Medical Center Groningen 201
Testing effectiveness (Phase 2)Ended earlyNCT01697293What this trial is testingPTX-200, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide in Treating Patients With Stage IIB-IV Breast CancerWho this might be right forBreast AdenocarcinomaEstrogen Receptor PositiveHER2/Neu Negative+6 more Prescient Therapeutics, Ltd. 34
Early research (Phase 1)Study completedNCT00544804What this trial is testingLapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2Who this might be right forBreast CancerMetastatic Cancer University of California, San Francisco 41
Testing effectiveness (Phase 2)Study completedNCT00255788What this trial is testingEverolimus in Treating Patients WIth Recurrent or Metastatic Breast CancerWho this might be right forBreast Cancer NCIC Clinical Trials Group 49
Testing effectiveness (Phase 2)WithdrawnNCT03803761What this trial is testingA New Drug Combination, Copanlisib and Fulvestrant, in Advanced Breast CancerWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Malignant Neoplasm in the Brain+1 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00275041What this trial is testingIrinotecan and Cetuximab in Treating Patients With Metastatic Breast CancerWho this might be right forBreast Cancer Alliance for Clinical Trials in Oncology 21
Testing effectiveness (Phase 2)Study completedNCT00410813What this trial is testingS0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the BoneWho this might be right forBreast CancerMetastatic Cancer SWOG Cancer Research Network 85
Testing effectiveness (Phase 2)UnknownNCT00006120What this trial is testingDocetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast CancerWho this might be right forBreast Cancer GERCOR - Multidisciplinary Oncology Cooperative Group
Testing effectiveness (Phase 2)Study completedNCT00049062What this trial is testingAnastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast CancerWho this might be right forBreast Cancer The University of Texas Health Science Center at San Antonio
Not applicableUnknownNCT02188693What this trial is testingGemcitabine as a Single Agent in the Maintenance Chemotherapy of Patients With Metastatic Breast CancerWho this might be right forStage IIIB, IV, Recurrent, and Metastatic Breast CancerGemcitabineMaintenance Chemotherapy Xijing Hospital 267
Testing effectiveness (Phase 2)Study completedNCT02448771What this trial is testingPalbociclib in Combination With Bazedoxifene in Hormone Receptor Positive Breast CancerWho this might be right forBreast Cancer Stage IVUnresectable Locally Advanced Invasive Breast CancerMetastatic Invasive Breast Cancer Dana-Farber Cancer Institute 36
Large-scale testing (Phase 3)Ended earlyNCT00272987What this trial is testingErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and LapatinibWho this might be right forNeoplasms, Breast Novartis Pharmaceuticals 63
Not applicableEnded earlyNCT00019643What this trial is testingFactors Affecting Weight Gain in Women Receiving Adjuvant Chemotherapy for Breast CancerWho this might be right forDepressionStage I Breast CancerStage IIIA Breast Cancer+4 more National Institutes of Health Clinical Center (CC) 26
Not applicableStudy completedNCT00896376What this trial is testingTrastuzumab in Treating Women With Metastatic Breast CancerWho this might be right forBreast Cancer Centre Antoine Lacassagne 49
Testing effectiveness (Phase 2)Study completedNCT00004182What this trial is testingIrinotecan in Treating Patients With Metastatic or Recurrent Breast CancerWho this might be right forBreast Cancer Northwestern University
Testing effectiveness (Phase 2)Study completedNCT00100750What this trial is testingTipifarnib and Gemcitabine Hydrochloride in Treating Women With Metastatic Breast CancerWho this might be right forRecurrent Breast CarcinomaStage IV Breast Cancer National Cancer Institute (NCI) 31